PROPERTY AND EQUIPMENT

12 Months Ended

Dec. 31, 2011

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment Disclosure [Text Block]

Note 3 – Property and Equipment

Property and equipment consists of the following:

	DECEMBER 31,
	2011			2010
Medical equipment and facilities	$	80,647,000		$	74,356,000
Office equipment		692,000			685,000
Deposits and construction in progress		4,764,000			6,479,000
Deposits towards purchase of proton beam systems		2,500,000			2,500,000
		88,603,000			84,020,000
Accumulated depreciation		(35,336,000	)		(36,660,000	)
Net property and equipment	$	53,267,000		$	47,360,000

The Company has equipment that is secured under capitalized leases, which is included in Medical equipment and facilities, with a total cost of $41,306,000 and associated accumulated depreciation of $15,122,000 as of December 31, 2011, and total cost of $28,727,000 and associated accumulated depreciation of $10,706,000 as of December 31, 2010.

As of December 31, 2011, the Company has $2,500,000 in deposits toward the purchase of three MEVION S250 proton beam radiation therapy (“PBRT”) systems from Mevion Medical Systems, Inc., a development-stage company. For the first two machines, the Company has a commitment to total deposits of $3,000,000 per machine until FDA approval is received, at which time the remaining balance is committed. The delivery dates for the first two machines are now anticipated to be in 2013 and 2014. For the third machine, the Company has a commitment to total deposits of $500,000 until FDA approval is received, at which time the remaining balance is committed. The Company has entered into a partnership agreement with a radiation oncology physician group, which has contributed $100,000 towards the deposits on the third machine. The Mevion PBRT system is not commercially proven and there is no assurance FDA approval will be received. The Company reviews the carrying value of these deposits for impairment on a quarterly basis, or as events or circumstances might indicate that the carrying value may not be recoverable. See Note 12-Commitments and Contingencies for additional discussion on purchase commitments.